Angelo, Gordon & Co. Adds Adviser To Private Equity Group

Jun 2 2010 | 9:50am ET

Angelo, Gordon & Co. has tapped J. Wayne Merck to join the firm’s private equity group as a senior adviser.  Merck will also serve on the board of the firm’s portfolio company, paintball-maker KEE Action Sports.

“Wayne’s experience in the consumer goods and sporting equipment industries is a great asset to our firm as we explore investment opportunities in his areas of expertise,” said David Roberts, senior managing director and co-head of Angelo Gordon’s private equity and special situations activities.  “He will also be instrumental in helping KEE Action Sports execute its strategy going forward.”

Prior to joining Angelo Gordon, Merck was most recently director, president and CEO of K2 Inc., where he had worked in various roles and divisions since 1991.  He was instrumental in the growth of K2 Inc. through both organic growth and acquisitions from under $600 million in revenue in 2002 to approximately $1.5 billion in 2007. In 2007, Merck helped facilitate the sale of K2 Inc. to Jarden Corp. and supported the integration into Jarden through 2008. 

Angelo Gordon’s private equity group is currently investing its fourth fund, which closed at the end of 2008.  The team makes control investments with deal sizes ranging from $50 million to $500 million.  Sector expertise includes business services, financial services, healthcare services, and consumer/retail.


In Depth

PAAMCO: Will Inflation Deflate the Asset Bubble?

Jan 30 2018 | 9:49pm ET

As the U.S. shifts from monetary stimulus to fiscal stimulus, market pricing should...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Boost Hedge Fund Marketing ROI By Raising Your ROO

Feb 14 2018 | 9:57pm ET

Tasked with delivering returns on client capital, a common dilemma for many alternative...

 

FINalternatives Trending

From the current issue of